[Mesangioproliferative IgA-nephritis in a patient with lyme borreliosis].
Zachäus
Markus
M
Facharzt für Innere Medizin und Gastroenterologie, Klinik für Innere Medizin II, Park-Krankenhaus Leipzig-Südost GmbH. markus.zachaeus@parkkrankenhaus-leipzig.de
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001706:Biopsy; D025065:Borrelia burgdorferi; D002443:Ceftriaxone / Q000008:administration & dosage / Q000627:therapeutic use; D005500:Follow-Up Studies; D005922:Glomerulonephritis, IGA / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology; D006801:Humans; D007668:Kidney / Q000473:pathology; D008193:Lyme Disease / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D002443:Ceftriaxone